Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response.
Breast Cancer (Dove Medical Press)
Jernström, Sandra S; Hongisto, Vesa V; Leivonen, Suvi-Katri SK; Due, Eldri Undlien EU; Tadele, Dagim Shiferaw DS; Edgren, Henrik H; Kallioniemi, Olli O; Perälä, Merja M; Mælandsmo, Gunhild Mari GM; Sahlberg, Kristine Kleivi KK